In autoimmune hypothyroidism patients with low IGF-I, two patients had a GHRH/GHRP‑6-stimulated GH peak below the 2.5th percentile.
In plain wordsIn patients with autoimmune hypothyroidism and low IGF-I, two had a low growth hormone peak after GHRH/GHRP‑6 testing.
- Peptide
- GHRP-6
- Outcome
- Not applicableLow stimulated GH peak
- Study
n = 49
- Outcome group
- Growth hormone and IGF-1 · Endocrine and hormones
Measurements
- Patients with GH peak below the 2.5th percentile
- 2 patients
- Patients with IGF-I below the 10th percentile tested with GHRH/GHRP-6
Source sentences
Two patients had a GH peak below the 2.5th percentile.
3 context sentences(design, population, supporting numbers)
In the remaining study population of 515 patients (476 female, 39 male), 49 patients (9.5%) had an IGF-I concentration below the 10th percentile.
If the IGF-I concentration was below the 10th percentile of age-specific reference values, a GHRH/GH-releasing peptide (GHRP)-6 test was done. GHD was defined as a GH peak after GHRH/GHRP-6 below the 2.5th percentile of age-specific reference values.
These patients underwent a GHRH/GHRP-6 test.
In this study, GHRP-6 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking GHRP-6.